⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13210453 | 0.87 | — | — | |
| SCHEMBL11579453 | 0.84 | — | — | |
| SCHEMBL1149444 | 0.81 | — | — | |
| SCHEMBL3273781 | 0.77 | — | — | |
| SCHEMBL3038121 | 0.77 | — | — | |
| SCHEMBL13509306 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL29248712 | 0.74 | — | — | |
| SCHEMBL27975063 | 0.74 | — | — | |
| SCHEMBL9837943 | 0.74 | — | — | |
| SCHEMBL13073742 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207412-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207412-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-11701427-B2 | Diels-alder conjugation methods | REGENERON PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-11701427-B2 | Diels-alder conjugation methods | REGENERON PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| WO-2021211984-A1 | DIELS-ALDER CONJUGATION METHODS | REGENERON PHARMACEUTICALS, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| US-20210198237-A1 | PIPERIDINES AS MENIN INHIBITORS | UNIV MICHIGAN REGENTS (US) | 2021-07-01 | — | — | US | disclosed |
| EP-2598110-B1 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES | UNILEVER PLC (GB) | 2015-09-02 | — | — | EP | disclosed |
| EP-2598110-A2 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES | Unilever PLC (GB) | 2013-06-05 | — | — | EP | disclosed |
| WO-2013039243-A1 | PATTERN-FORMING METHOD, ELECTRON BEAM-SENSITIVE OR EXTREME ULTRAVIOLET RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE USING THEM AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2013-03-21 | — | — | WO | disclosed |
| EP-2562163-A1 | 5-FLUORO PYRIMIDINE DERIVATIVES AS FUNGICIDES | Dow AgroSciences LLC (US) | 2013-02-27 | — | — | EP | disclosed |
| US-20120027699-A1 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES | CONOPCO, INC., D/B/A UNILEVER (US) | 2012-02-02 | — | — | US | disclosed |
| WO-2012013418-A2 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES | UNILEVER PLC (GB) | 2012-02-02 | — | — | WO | disclosed |
| WO-2011108744-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-09-09 | — | — | WO | disclosed |
| EP-2132194-B1 | SUBSTITUTED ISOQUINOLINES AND THEIR USE AS RHO-KINASE INHIBITORS | SANOFI AVENTIS (FR) | 2011-03-16 | — | — | EP | disclosed |
| WO-2010114107-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010067905-A2 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-06-17 | — | — | WO | disclosed |
| WO-2008014221-A2 | BRIDGED CARBAMATE MACROLIDES | ENANTA PHARMACEUTICALS, INC. (US) | 2008-01-31 | — | — | WO | disclosed |
| EP-0011608-A1 | Novel allenic amine and acid addition salts thereof, a process for their preparation, pharmaceutical preparations comprising them and the use of these compounds in the preparation of pharmaceutical compositions | Astra Läkemedel Aktiebolag (SE) | 1980-05-28 | — | — | EP | disclosed |
| US-4149001-A | ANTIINFLAMMATORY AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1979-04-10 | — | — | US | disclosed |
| US-4131744-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1978-12-26 | — | — | US | disclosed |